C-Arm Devices Market Will Generate Booming Growth Opportunities to 2032

The utilization of C-arm devices is expected to rise due to their ability to provide high-resolution X-ray images in real-time, enabling clinicians to monitor progress throughout surgeries.

The global C-arm devices market was valued at US$ 1.7 billion in 2019, and it is projected to reach US$ 2.45 billion by 2027, with a Compound Annual Growth Rate (CAGR) of 4.2% between 2022 and 2032.

The North American C-arm device market is anticipated to have a substantial share owing to a high frequency of diagnostic testing, an aging population, and a growing incidence of chronic illnesses. The United States, in particular, is experiencing a strong demand for C-arm devices due to increased medical imaging technology expertise, financial stability to purchase expensive devices, and acceptance of innovative products. Additionally, the country's growing investment in medical and healthcare infrastructure serves as a boost for C-arm device sales.

Following North America, the Asia Pacific C-arm devices market is predicted to experience the fastest CAGR, driven by increasing demand in diagnostic and interventional radiology procedures. The presence of established hospitals and a large target customer base are expected to drive C-arm device sales in China. Meanwhile, in India, rising population awareness and rapid medical tourism are likely to boost C-arm device sales in the Asia-Pacific region.

Key Players

The writer will create content on the general strategies of market players. And then will write the key players in the market are: GE Healthcare Inc., Philips Healthcare, Siemens AG, Hologic corp., BMI Biomedical International s.r.l., DMS Health Technologies, Medonica Co., Ltd., Gemss Co. Ltd., Shimadzu Corp.

Browse More@ https://www.futuremarketinsights.com/reports/c-arms-devices-market

Segmentation

The report provides insights on the important highlights and current trends prevailing in the market. This helps the readers to gain a deeper understanding and form an unbiased opinion on the market. Numerous segmentations have been provided for this market based on:

By Type:

  • Fixed C-Arms
  • Mobile C-Arms

By Application:

  • Cardiology
  • Gastroenterology
  • Neurology
  • Orthopaedics and Trauma
  • Oncology
  • Other Applications

Comments

Post a Comment

Popular posts from this blog

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

A Safer Tomorrow | Emerging Trends in Hospital-Acquired Infection Control Market

Image
According to Future Market Insights' recently released Hospital-acquired Infection Control Market analysis report, global Hospital-acquired Infection Control sales in 2023 are expected to be US$ 6.5 billion. The market is expected to increase at a CAGR of 7% between 2023 and 2033, reaching $12.7 billion by 2033. Hospitals and intensive care units are predicted to create significant income in the market, with a CAGR of 7.6%. The occurrence of hospital-acquired infections, increasing proportion of surgical procedures, growing geriatric population and increasing prevalence of chronic diseases, technological advancements in sterilisation equipment, and growing awareness of environmental and personal hygiene are the key factors driving the Hospital-acquired infection control market. The increased use of e-beam sterilisation, as well as the reintroduction of ethylene oxide sterilisation, is predicted to increase demand for hospital-acquired infection management. The percentage of treatm
Read more

Transforming Trauma | Emerging Therapies and Interventions in Post-Traumatic Stress Disorder Treatment Market

Image
According to Future Market Insights, the Post-Traumatic Stress Disorder (PTSD) Treatment Market Sales would grow at a 5% CAGR between 2023 and 2033. By 2033, the global market for post-traumatic stress disorder (PTSD) therapy is expected to reach US$ 27.37 billion. The market's growth might be attributed to the increased prevalence of PTSD globally. According to the National Centre for PTSD, approximately 7-8% of the US population will develop PTSD at some point in their lives, with greater percentages among military veterans and persons who have experienced sexual assault or other types of trauma. The COVID-19 pandemic has also been highlighted as a possible cause of PTSD, with healthcare workers, first responders, and people immediately impacted by the virus being especially vulnerable. In addition, there is a growing emphasis on using digital therapies and other non-pharmacological techniques to treat PTSD. For example, virtual reality exposure treatment (VRET) has shown potent
Read more